‹ All Posts
Umang Bhutada

21st Jan · SEBI-Registered Analyst

JB Chemicals & Pharmaceuticals Ltd – 1D

JBCHEPHARM
1) Important Levels Strong base around 1635–1650 Intermediate support near 1840–1850 Major resistance zone at 2030 (supply zone / overhead resistance) 2) Business Mid-sized pharmaceutical company with strong presence in branded generics, domestic formulations, and steady export exposure. Known for consistent operational performance. 3) Earnings Stable earnings profile with improving margins, controlled debt, and consistent cash generation. No major balance sheet stress visible. 4) Verdict Structure remains bullish within an ascending channel. Price holding above key supports indicates strength. A sustained move beyond the upper supply zone can open further upside over time.

#FundamentalViews#TechnicalViews
JBCHEPHARM_2026-01-20_23-44-26.png
482 likes·42 comments